Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Avience BiomedicalsNSE:AVIENCE -0.38%18 Days Payable is 86.43 as of Mar. 2025, which is 8% above its 10-year median of 79.86. GuruFocus rates NSE:AVIENCE with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Avience Biomedicals ranks better than 59.5% on this metric.
The historical rank and industry rank for Avience Biomedicals's Days Payable or its related term are showing as below:
NSE:AVIENCE'
s Days Payable Range Over the Past 10 Years
Min: 59.66 Med: 79.86 Max: 86.43
Current: 86.43
During the past 3 years, Avience Biomedicals's highest Days Payable was 86.43. The lowest was 59.66. And the median was 79.86.
NSE:AVIENCE's Days Payable is ranked better than 59.5% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.21
vs NSE:AVIENCE: 86.43
Avience Biomedicals's Days Payable
increased
from Mar. 2023 (59.66) to Mar. 2025 (86.43).
It may suggest that Avience Biomedicalsdelayed paying its suppliers.
The historical data trend for Avience Biomedicals's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avience Biomedicals Days Payable Chart
Avience Biomedicals Annual Data
Trend
Mar23
Mar24
Mar25
Days Payable
59.66
79.86
86.43
Avience Biomedicals Semi-Annual Data
Mar23
Mar24
Mar25
Days Payable
59.66
79.86
86.43
NSE:AVIENCE vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Avience Biomedicals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avience Biomedicals Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avience Biomedicals's Days Payable distribution charts can be found below:
* The bar in red indicates where Avience Biomedicals's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Avience Biomedicals's Days Payable for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avience Biomedicals (NSE:AVIENCE) has a Days Payable of 86.43 as of Mar. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Avience Biomedicals and its competitors. This is near median its historical median of 79.86. Over the past decade, Avience Biomedicals' Days Payable has ranged from 59.66 to 86.43. According to the industry distribution chart, Avience Biomedicals ranks #322 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 40.5%.
Is Avience Biomedicals' Days Payable too high?
Avience Biomedicals' current Days Payable of 86.43 is near median its 10-year median of 79.86. Over the past 10 years, this metric has ranged from a low of 59.66 to a high of 86.43. The Medical Devices & Instruments industry median Days Payable is 68.21. Avience Biomedicals' value of 86.43 is 26.7% above this industry median. Based on the distribution chart, Avience Biomedicals ranks #322 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Avience Biomedicals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Avience Biomedicals ranks #322 out of 795 companies for Days Payable. This puts Avience Biomedicals in the upper half of its industry. The industry median Days Payable is 68.21. Avience Biomedicals' value of 86.43 is 26.7% above this benchmark. Historically, Avience Biomedicals' own Days Payable has ranged from 59.66 to 86.43 over the past decade. While the company's 10-year median is 79.86 vs. the industry median of 68.21, Avience Biomedicals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.21, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avience Biomedicals's current Days Payable of 86.43 is 26.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Avience Biomedicals and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avience Biomedicals's current Days Payable is 86.43, which is near median its own 10-year median of 79.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Days Payable of 86.43. The current Days Payable is 86.43, which is near median its 10-year median of 79.86 and 26.7% above the Medical Devices & Instruments industry median of 68.21. Avience Biomedicals' overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Days Payable is 86.43 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
18GF Score
Get the complete analysis for NSE:AVIENCE
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AVIENCE has been successfully added to your 
